Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hypopituitarism/potassium
L'enllaç es desa al porta-retalls
Pàgina 1 des de 23 resultats
[Neurogenic hypernatremia. Apropos of a case of neurogenic hypernatremia in the course of an ectopic pinealoma of the chiasma, causing a global pituitary insufficiency. Study of exchangeable sodium and potassium].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE
To assess cardiac structure and function in patients with treated hypopituitarism and to determine their relation to the degree of growth hormone deficiency and body composition pattern.
METHODS
26 patients with treated hypopituitarism were studied by cross sectional and Doppler
[The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Although angiotensin II, ACTH and potassium are generally acknowledged as major factors in regulating the influences on aldosterone secretion, it has recently been reported that dopamine is a potent inhibitor of aldosterone secretion in man and animals. In the present study, we investigated the
A patient with pseudohypoaldosteronism type II complicated by congenital hypopituitarism carrying a KLHL3 mutation.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Pseudohypoaldosteronism type II (PHA II) is a renal tubular disease that causes hyperkalemia, hypertension, and metabolic acidosis. Mutations in four genes (WNK4, WNK1, KLHL3, and CUL3) are known to cause PHA II. We report a patient with PHA II carrying a KLHL3 mutation, who also had congenital
Acute pituitary insufficiency and hypokalaemia following envenoming by Russell's viper (Daboia russelii) in Sri Lanka: Exploring the pathophysiological mechanisms.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Russell's viper envenoming is associated with a high incidence of morbidity and mortality. Hypopituitarism following envenoming by Russell's vipers is a well recognized sequel in Burma and parts of India but has been reported only once in Sri Lanka. Hypokalaemia following envenoming by Russell's
Hypopituitarism: a difficult diagnosis in elderly people but worth a search.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Hypopituitarism is uncommon in elderly people. We report 12 cases of hypopituitarism diagnosed after the age of 60 (range 63-89, mean 74.9) years over a 10-year period. Aetiology was evident in eight cases, viz. pituitary tumour in six and previous post-partum haemorrhage and giant aneurysm of
A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A 55-year-old man with normotensive primary aldosteronism, hypopituitarism, epilepsy, and medullary sponge kidney is reported. Seventeen years before admission, he had been noted to have hypokalemia associated with high potassium clearance, suppressed plasma renin activity, metabolic alkalosis, and
[Hyponatremia, a frequent, and at times a major and indicative sign in anterior pituitary insufficiency].
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Thirty five patients with hypopituitarism have been studied. Nine had a mild hyponatremia (126-137 mEq/l) and five a profound hyponatremia (105-124 mEq/l). None of them had hemodilution (plasma protein, potassium were normal). Hyponatremia was present even in the absence of deficit in GH and/or TSH,
A case of torsade de pointes associated with hypopituitarism due to hemorrhagic fever with renal syndrome.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We describe a 51-yr-old man presenting with syncope due to torsade de pointes. The torsade de pointes was refractory to conventional medical therapy, including infusion of isoproterenol, MgSO4, potassium, lidocaine, and amiodarone. His past history, physical findings, and hormone study confirmed
Incomplete deficiency of hypothalamic hormones in hypothalamic hypopituitarism associated with an old traumatic brain injury.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
A 62 year-old man was admitted to determine the pathogenesis of his hypoglycemia. He was unconscious and his plasma glucose level was 26 mg/dL. When he was 31 years old, he had a traffic accident and was unconscious for several days. Physical findings on admittance showed that the patient's BMI was
Two missense mutations in KCNQ1 cause pituitary hormone deficiency and maternally inherited gingival fibromatosis.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Familial growth hormone deficiency provides an opportunity to identify new genetic causes of short stature. Here we combine linkage analysis with whole-genome resequencing in patients with growth hormone deficiency and maternally inherited gingival fibromatosis. We report that patients from three
Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Six patients (21-50 years) with growth hormone deficiency and panhypopituitarism were given recombinant growth hormone, somatotropin, 0.04-0.1 U.kg.body wt-1.day-1, for 12 months. All patients reported improved well-being with increased working capacity. Bone mineral density, as measured by single
Fatal high-grade skull osteosarcoma 30 years following radiotherapy for Cushing's disease
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Summary: Cushing's disease is a rare disorder characterised by excessive cortisol production as a consequence of a corticotroph pituitary tumour. While the primary treatment is surgical resection, post-operative radiation therapy may be
A case of hypokalemic paralysis in a patient with neurogenic diabetes insipidus.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Acute hypokalemic paralysis is characterized by muscle weakness or paralysis secondary to low serum potassium levels. Neurogenic diabetes insipidus (DI) is a condition where the patient excretes large volume of dilute urine due to low levels of antidiuretic hormone. Here, we describe a patient with
Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We analyzed the serum anion gap (AG = sodium plus potassium minus chloride plus bicarbonate, N = 11-21 mEq/l), serum uric acid and urea concentrations in hyponatremia of various origins. We found that characteristic chemical patterns emerged in association with different hypotonic states: Low uric
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
